Drugs / Faster-acting aspart insulin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04381429 Comparator | Aug 2020 → Jan 2025 | cystic fibrosis-related diabetes | University Hospital, Strasbourg, France | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Faster-acting aspart insulin | “A = pre-prandial aspart insulin (NovoRapid) F = post prandial Faster-acting aspart insulin (FIASP)” NCT04381429 ↗ |
| Known as | FIASP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04381429 ↗ |
| Modality | Protein / enzyme biologic | “post prandial Faster-acting aspart insulin (FIASP)” NCT04381429 ↗ |